Skip to main content

OCULAR THERAPEUTIX, INC

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

OCUL$6.85+3.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

The exhibits filed as part of this Quarterly Report on Form 10-Q are set forth on the following Exhibit Index.

Exhibit Index

​​​​​​​​​​​​​
​ · ​ · ​ · ​ · Incorporated by Reference
ExhibitNumber​ ​ ​Description of Exhibit​ ​Form​ ​File Number​ ​Date of Filing​ ​ ​Exhibit Number​ ​ ​Filed Herewith
10.1​Amendment No. 5 to 2019 Inducement Stock Incentive Plan​S-8​333-293220​2/5/2026​99.6​​
​​​​​​​​​​​​​
10.2​Sublease Agreement, by and between Quanterix Corporation and the Registrant, dated as of January 1, 2026​​​​​​​​​X
​​​​​​​​​​​​​
10.3​Employment Agreement by and between the Registrant and David Robinson, dated as of January 20, 2026​​​​​​​​​X
​​​​​​​​​​​​​
10.4​Employment Agreement by and between the Registrant and Jason S. Robins, dated as of April 15, 2026​​​​​​​​​X
​​​​​​​​​​​​​
31.1​Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
31.2​Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
32.1​Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
32.2​Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.INS​Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document)​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.SCH​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.CAL​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.LAB​Inline XBRL Taxonomy Extension Label Linkbase Database​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.PRE​Inline XBRL Taxonomy Extension Presentation Linkbase Document​​​​​​​​​X
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
101.DEF​Inline XBRL Taxonomy Extension Definition Linkbase Document​​​​​​​​​X
​​​​​​​​​​​​​
104​The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101​​​​​​​​​X
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.